Nektar Therapeutics (NKTR) PT Raised to $69 at Jefferies, 'data update gives us further confidence in Rezpeg's potential'
Tweet Send to a Friend
(Updated - June 24, 2025 3:41 PM EDT)
Jefferies analyst Roger Song raised the price target on Nektar Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Roger Song raised the price target on Nektar Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
